自动化和封闭式细胞治疗处理系统市场 - 全球产业规模、份额、趋势、机会和预测，按工作流程、类型、规模、地区和竞争细分，2020-2030 年预测

2024 年全球自动化和封闭细胞治疗处理系统市值为 9.3108 亿美元，预计到 2030 年将达到 15.973 亿美元，预测期内复合年增长率为 9.37%。再生医学和细胞疗法日益增长的吸引力，以及自动化技术在其发展过程中带来的众多优势，预计将推动市场扩张。此外，软体技术越来越多地融入先进的治疗开发程序中也有望刺激市场成长。此外，在多轮融资的支持下，生物製药製造商对细胞治疗产品开发的投资不断增加，将为市场提供诱人的成长前景。

主要市场驱动因素

再生医学和细胞疗法日益普及

主要市场挑战

初始成本高

主要市场趋势

越来越多地采用自动化系统来提高效率和一致性

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球自动化与封闭式细胞治疗处理系统市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依工作流程（分离、扩增、血液分离、填充、冷冻保存、其他）
  • 依类型（干细胞疗法、非干细胞疗法）
  • 依规模划分（预商业化/研发规模、商业化规模）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第 6 章：北美自动化与封闭式细胞治疗处理系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 加拿大
  • 墨西哥

第 7 章：欧洲自动化与封闭式细胞治疗处理系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区自动化与封闭式细胞治疗处理系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲自动化与封闭式细胞治疗处理系统市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲自动化和封闭式细胞治疗处理系统市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如果有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Miltenyi Biotec BV & Co. KG
• Lonza Group AG
• Fresenius Kabi AG
• Global Life Sciences Solutions USA LLC
• BioSpherix, LLC
• Terumo Corp
• Sartorius AG
• ThermoGenesis Holdings Inc
• Cellares Corporation
• Thermo Fisher Scientific Inc

第 15 章：策略建议

第16章 调査会社について・免责事项

Global Automated And Closed Cell Therapy Processing Systems Market has valued at USD 931.08 Million in 2024 and is expected to reach USD 1597.30 Million by 2030 with a CAGR of 9.37% during the forecast period. The increasing appeal of regenerative medicine and cell therapies, along with the numerous advantages associated with automation technologies in their development, is projected to drive market expansion. Moreover, the increasing incorporation of software technologies into advanced therapy development procedures is also expected to stimulate market growth. Additionally, the rising investments made by biopharmaceutical manufacturers in the development of cellular therapy products, supported by multiple rounds of funding, are poised to provide attractive growth prospects for the market.

Key Market Drivers

Growing Popularity of Regenerative Medicine and Cell Therapies

Regenerative medicine and cell therapies represent a groundbreaking frontier in modern healthcare, offering new hope for treating a variety of challenging medical conditions. As these therapies gain momentum and continue to demonstrate their effectiveness, they are poised to significantly impact the healthcare industry. One crucial factor enabling the scalability and efficiency of regenerative medicine and cell therapy production is the adoption of automated and closed cell therapy processing systems.

The increasing popularity of regenerative medicine and cell therapies has led to a surge in demand for these groundbreaking treatments. However, with greater demand comes the need for efficient, scalable, and consistent manufacturing processes. Automated and closed cell therapy processing systems offer a solution to this challenge. They can handle large-scale production while maintaining precise control over cell culture conditions. This scalability is essential to meet the growing global demand for these therapies. In June 2024, Cryoport Systems, LLC joined forces with Minaris Regenerative Medicine to advance the development of cell and gene therapies. This partnership is centered on offering integrated solutions for the storage, transportation, and processing of cell and gene-based products. The collaboration aims to facilitate the commercialization and clinical trials of regenerative therapies.

Key Market Challenges

High Initial Costs

One of the most significant barriers to the adoption of automated cell therapy processing systems is the high initial cost associated with acquiring and implementing these advanced technologies. The investment required to purchase, install, and configure such systems can be substantial, often running into the millions of dollars. This poses a particular challenge for smaller biotech companies and research institutions that may lack the financial resources to make such large investments. Additionally, the long-term return on investment (ROI) may not be immediately clear, leading to hesitation among potential stakeholders. The financial strain associated with these initial costs can deter many from entering the market or adopting these systems, despite the potential long-term benefits in terms of efficiency, scalability, and precision.

Key Market Trends

Increasing Adoption of Automated Systems for Efficiency and Consistency

The demand for automated cell therapy processing systems is rising globally due to the need for increased efficiency and consistency in manufacturing processes. Cell therapy, which includes innovative treatments such as stem cell and gene therapies, has complex production requirements that necessitate precise control over various parameters, including temperature, oxygen levels, and pH. Traditionally, manual processing could result in variability and human error, which compromises product quality and consistency. Automated systems are designed to standardize processes and reduce errors, ensuring more reliable outcomes.

Key Market Players

• Miltenyi Biotec B.V. & Co. KG
• Lonza Group AG
• Fresenius Kabi AG
• Global Life Sciences Solutions USA LLC
• BioSpherix, LLC
• Terumo Corp
• Sartorius AG
• ThermoGenesis Holdings Inc
• Cellares Corporation
• Thermo Fisher Scientific Inc.

Report Scope:

In this report, the Global Automated And Closed Cell Therapy Processing Systems Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Automated And Closed Cell Therapy Processing Systems Market, By Workflow:

• Separation
• Expansion
• Apheresis
• Fill-Finish
• Cryopreservation
• Others

Automated And Closed Cell Therapy Processing Systems Market, By Type:

• Stem Cell Therapy
• Non-Stem Cell Therapy

Automated And Closed Cell Therapy Processing Systems Market, By Scale:

• Pre-commercial/ R&D Scale
• Commercial Scale

Automated And Closed Cell Therapy Processing Systems Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Automated And Closed Cell Therapy Processing Systems Market.

Available Customizations:

Global Automated And Closed Cell Therapy Processing Systems market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Automated And Closed Cell Therapy Processing Systems Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Workflow (Separation, Expansion, Apheresis, Fill-Finish, Cryopreservation, Others)
  • 5.2.2. By Type (Stem Cell Therapy, Non-Stem Cell Therapy)
  • 5.2.3. By Scale (Pre-commercial/ R&D Scale, Commercial Scale)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Automated And Closed Cell Therapy Processing Systems Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Workflow
  • 6.2.2. By Type
  • 6.2.3. By Scale
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Workflow
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Scale
  • 6.3.2. Canada Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Workflow
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Scale
  • 6.3.3. Mexico Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Workflow
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Scale

7. Europe Automated And Closed Cell Therapy Processing Systems Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Workflow
  • 7.2.2. By Type
  • 7.2.3. By Scale
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Workflow
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Scale
  • 7.3.2. United Kingdom Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Workflow
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Scale
  • 7.3.3. Italy Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Workflow
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Scale
  • 7.3.4. France Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Workflow
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Scale
  • 7.3.5. Spain Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Workflow
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Scale

8. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Workflow
  • 8.2.2. By Type
  • 8.2.3. By Scale
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Workflow
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Scale
  • 8.3.2. India Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Workflow
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Scale
  • 8.3.3. Japan Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Workflow
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Scale
  • 8.3.4. South Korea Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Workflow
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Scale
  • 8.3.5. Australia Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Workflow
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Scale

9. South America Automated And Closed Cell Therapy Processing Systems Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Workflow
  • 9.2.2. By Type
  • 9.2.3. By Scale
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Workflow
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Scale
  • 9.3.2. Argentina Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Workflow
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Scale
  • 9.3.3. Colombia Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Workflow
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Scale

10. Middle East and Africa Automated And Closed Cell Therapy Processing Systems Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Workflow
  • 10.2.2. By Type
  • 10.2.3. By Scale
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Workflow
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Scale
  • 10.3.2. Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Workflow
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Scale
  • 10.3.3. UAE Automated And Closed Cell Therapy Processing Systems Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Workflow
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Scale

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Miltenyi Biotec B.V. & Co. KG
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Lonza Group AG
• 14.3. Fresenius Kabi AG
• 14.4. Global Life Sciences Solutions USA LLC
• 14.5. BioSpherix, LLC
• 14.6. Terumo Corp
• 14.7. Sartorius AG
• 14.8. ThermoGenesis Holdings Inc
• 14.9. Cellares Corporation
• 14.10. Thermo Fisher Scientific Inc

15. Strategic Recommendations

16. About Us & Disclaimer